KORU Medical Systems Inc
KRMD
Get informed when a big investor buys or sells
+ FollowMarket Cap$149.28M
Close$
$-4.01
226.6% downside
Current Fair Value
226.6% downsideOvervalued by 226.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $149.28 Million |
|---|---|
| Enterprise Value | $144.23 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.06 |
| Beta | 0.41 |
| Outstanding Shares | 46,083,893 |
Return
| Return on Equity | -10.08% |
|---|---|
| Return on Assets | -6.51% |
| Return on Invested Capital | -7.27% |
Valuation & Multiples
| P/E Ratio | -82.91 |
|---|---|
| PEG | 37.34 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3.2 |
| Enterprise Value to EBIT | -95.44 |
| Enterprise Value to Net Income | -80 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$-0.02
Average shareholder expectationRevenue Estimate
$11.62 M
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.02
Average shareholder expectationRevenue Estimate
$11.33 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 44.91%▼ 0.05% |
|---|---|
| Total Invested | $87.52M▼ 2.79% |
| Investors Holding | 87▼ 6.00% |
ESG Score
No data
About Repro-Med Systems, Inc.
101 employeesRepro Med Systems, Inc. dba KORU Medical System develops, manufactures, and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion S...